Piga, Felisa M.

HRN: 27-13-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/20/2026
04/27/2026
IV
600mg
Q8H
Abscess
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines